October 2014

Does renal disease increase one's risk of developing cancer?

The changes seen in multiple myeloma are a perfect illustration of a potentially shifting paradigm in cancer care.

The prostate cancer team at the Comprehensive Cancer Center at Wake Forest Baptist Medical Center has recently focused on two primary areas: minimally invasive care and clinical research.

A high level of tumor infiltrating lymphocytes (TILs) may be a marker of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer, especially in patients with triple-negative or HER2-positive disease